JX-594 (Pexa-Vec)

· Jennerex Biotherapeutics

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for JX-594 (Pexa-Vec), covering 2015-08-17 to 2016-01-21. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients [Phase 1]